Lymph node-positive bladder cancer: Surgical, pathologic, molecular and prognostic aspects

Jose A. Pedrosa, Michael O. Koch, Liang Cheng

Research output: Contribution to journalReview article

5 Scopus citations


The presence of lymphatic metastasis is associated with markedly worse prognosis in patients with bladder cancer, although surgical resection and chemotherapy can still provide long-term survival for selected patients. The prognostic stratification of patients with positive lymph nodes has been broadly discussed in the current literature and a more extensive pelvic lymph node dissection and thorough pathologic assessment has been advocated. It is clear that stratification using the tumor node metastasis staging system is insufficient to adequately discriminate prognosis between patients with different lymph node involvement. Lymph node density and extranodal extension have been extensively investigated and appear to influence the prognosis of these patients. Molecular markers have been developed to improve the diagnosis of micrometastatic disease, and new targeted therapies have shown promising preclinical results and are now being tested in different clinical scenarios.

Original languageEnglish (US)
Pages (from-to)1281-1295
Number of pages15
JournalExpert Review of Anticancer Therapy
Issue number11
StatePublished - Nov 14 2013


  • lymph node density
  • lymph node dissection/pelvic lymphadenectomy
  • lymph node-positive bladder cancer
  • staging
  • targeted therapy
  • transitional cell (urothelial) carcinoma
  • urinary bladder

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Fingerprint Dive into the research topics of 'Lymph node-positive bladder cancer: Surgical, pathologic, molecular and prognostic aspects'. Together they form a unique fingerprint.

  • Cite this